Clinical Trials Directory

Trials / Unknown

UnknownNCT05515835

Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.

Status
Unknown
Phase
Study type
Observational
Enrollment
88 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The induction dose of rocuronium is typically decided based on the patient's body weight, but the effect duration of rocuronium is variable. Some studies suggest that body composition analysis data, such as skeletal muscle mass or total body water, may correlate better with the duration time of rocuronium. Therefore, we plan to analyse body composition in patients undergoing total intravenous general anesthesia, give the patients a fixed dose (50mg) of rocuronium, and check the correlation between duration time of rocuronium and body composition analysis data.

Conditions

Interventions

TypeNameDescription
DEVICEbody composition analysisPatients will undergo body composition analysis using bioelectical impedance method before anesthesia.

Timeline

Start date
2022-09-05
Primary completion
2022-12-30
Completion
2023-03-01
First posted
2022-08-25
Last updated
2023-01-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05515835. Inclusion in this directory is not an endorsement.

Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data. (NCT05515835) · Clinical Trials Directory